Tolerogenic anti–IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity

Lignende værker

• Administration Of Anti-CD20 mAb Is Highly Effective In Preventing But Ineffective In Treating Chronic GVHD While Preserving Strong GVL Effects
  af: Johnston, Heather F., et al.
  Udgivet: (2014)
• IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice
  af: Song, Qingxiao, et al.
  Udgivet: (2021)
• Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.
  af: Sykes, M, et al.
  Udgivet: (1990)
• Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity
  af: Qingxiao Song, et al.
  Udgivet: (2022-05-01)
• Pharmacokinetic mAb–mAb Interaction: Anti-VEGF mAb Decreases the Distribution of Anti-CEA mAb into Colorectal Tumor Xenografts
  af: Abuqayyas, Lubna, et al.
  Udgivet: (2012)